Filing Details
- Accession Number:
- 0001104659-21-112596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-02 19:11:23
- Reporting Period:
- 2021-09-02
- Accepted Time:
- 2021-09-02 19:11:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1504167 | Timber Pharmaceuticals Inc. | TMBR | Pharmaceutical Preparations (2834) | 593843182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1800690 | Tardimed Sciences Llc | 303 South Broadway, Suite 125 Tarrytown NY 10591 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2021-09-02 | 225,000 | $0.94 | 3,508,567 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9011 to $0.9971, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Billionaire Hedge Funds
